Gastrointestinal Mucormycosis: A Clinical Review

被引：8

作者：

Addasi, Yazan ^{[1
]}

Nguyen, Anny H. ^{[2
]}

Sabri, Ahmed ^{[3
]}

Ahmad, Faran ^{[4
]}

Rangray, Rajani ^{[5
]}

Velagapudi, Manasa ^{[4
]}

机构：

[1] CHI Hlth Creighton Univ Med Ctr, Dept Internal Med, Omaha, NE USA

[2] Creighton Univ Sch Med, Omaha, NE USA

[3] CHI Hlth Creighton Univ Med Ctr, Dept Pathol, Omaha, NE USA

[4] CHI Hlth Creighton Univ Med Ctr, Dept Infect Dis, Omaha, NE USA

[5] CHI Hlth Creighton Univ Med Ctr, Div Gastroenterol, Omaha, NE USA

来源：

GASTROENTEROLOGY RESEARCH | 2023年 / 16卷 / 05期

关键词：

Risk factors; Gastrointestinal mucormycosis; Clinical; presentation; Diagnosis; Treatment; PERFORATION; ZYGOMYCOSIS; DIAGNOSIS;

D O I：

10.14740/gr1662

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Mucormycosis is a devastating fungal infection that is usually seen in immunocompromised hosts. It is caused by fungi of the subphylum Mucoromycotina, order Mucorales, with most cases caused by Mucor, Rhizopus, or Rhizomucor species. It can involve any organ system and can disseminate in severe cases. Lately, there has been an increased number of reports for mucormycosis infection in immunocompetent patients. Gastrointestinal system involvement is rare compared to other organ systems but has been increasingly reported in the literature. Mucormycosis can affect any part of the gastrointestinal tract and lead to different presentations depending on the area of involvement. Due to the paucity of the condition, there has been no specific guidelines on how to treat gastrointestinal mucormycosis. In this review, we discuss the risk factors of gastrointestinal mucormycosis, clinical presentation, approach to diagnosis, and most recent treatment modalities for gastrointestinal mucormycosis.

引用

页码：249 / 253

页数：5

共 26 条

[1] MUCORMYCOMA OF THE COLON - EARLY DIAGNOSIS AND SUCCESSFUL MANAGEMENT [J].

AGHA, FP ;

LEE, HH ;

BOLAND, CR ;

BRADLEY, SF .

AMERICAN JOURNAL OF ROENTGENOLOGY, 1985, 145 (04) :739-741

[2]

[Anonymous], 1981, Postgrad Med J, V57, P471

[3] Gastrointestinal mucormycosis resulting in a catastrophic outcome in an immunocompetent patient [J].

Antony, Suresh J. ;

Parikh, Monisha S. ;

Ramirez, Ruben ;

Applebaum, Bruce ;

Friedman, Glen ;

Do, Jennifer .

INFECTIOUS DISEASE REPORTS, 2015, 7 (03) :60-65

[4] Mucormycosis in India: unique features [J].

Chakrabarti, Arunaloke ;

Singh, Rachna .

MYCOSES, 2014, 57 :85-90

[5] Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with Hematologic malignancy who have zygomycosis [J].

Chamilos, Georgios ;

Lewis, Russell E. ;

Kontoyiannis, Dimitrios P. .

CLINICAL INFECTIOUS DISEASES, 2008, 47 (04) :503-509

[6] Gastrointestinal mucormycosis in immunocompromised hosts [J].

Dioverti, M. Veronica ;

Cawcutt, Kelly A. ;

Abidi, Maheen ;

Sohail, M. Rizwan ;

Walker, Randall C. ;

Osmon, Douglas R. .

MYCOSES, 2015, 58 (12) :714-718

[7] Improved outcome of zygomycosis in patients with hematological diseases? [J].

Gleissner, B ;

Schilling, A ;

Anagnostopolous, I ;

Siehl, I ;

Thiel, E .

LEUKEMIA & LYMPHOMA, 2004, 45 (07) :1351-1360

[8] An unusual cause of massive upper gastrointestinal bleeding-gastric mucormycosis [J].

Guddati, Harish ;

Andrade, Christopher ;

Muscarella, Peter ;

Hertan, Hilary .

OXFORD MEDICAL CASE REPORTS, 2019, (02) :88-91

[9]

Ha Tae Sun, 2015, Acute and Critical Care, V30, P323

[10] Spontaneous Gastric Necrosis: A Rare Presentation of Invasive Mucormycosis in an Immunocompetent Adult [J].

Hameed, Tariq ;

Jain, Sudhir Kumar ;

Ansari, Faiz Manzar ;

Nizam, Adiba ;

Dua, Amrita .

CASE REPORTS IN INFECTIOUS DISEASES, 2020, 2020

← 1 2 3 →